Browsing: GLP-1s
Yuling Luo rang the Nasdaq closing bell Friday having taken his first company public in a massively oversubscribed round. The…
Special menus with petite, less expensive portions are popping up all over, from large chains like Olive Garden and The…
The meat stick, long associated with truck stops and road trips, has undergone a rebranding. Fueled by a national obsession…
GLP-1s are the hottest drugs on the market. While doctors have prescribed these drugs to treat type-2 diabetes for decades,…
In this week’s edition of InnovationRx, we look at the battle for Metsera, the departure of FDA’s top drug regulator,…
Gallup released a survey this week showing that the obesity rate among US adults has fallen to 37% this year, a significant…
Madison Reed is rolling out an agentic-AI concierge to boost bookings and product discovery—on top of a hair-color subscription engine…
California recently passed a budget for 2025-2026 that eliminates Medicaid coverage for GLP-1 agonists for weight loss. Other states are…
In today’s edition: Jane Fraser’s meeting with Trump, some dark horse candidates for Fed chair, and a startup pivot that…
Millions more Americans should be taking weight-loss drugs to prevent heart disease, according to the American College of Cardiology. Exercise…